Do pulmonary rehabilitation programmes improve outcomes in patients with COPD posthospital discharge for exacerbation: a systematic review and meta-analysis.

COPD exacerbations exercise pulmonary rehabilitation

Journal

Thorax
ISSN: 1468-3296
Titre abrégé: Thorax
Pays: England
ID NLM: 0417353

Informations de publication

Date de publication:
13 Feb 2024
Historique:
received: 04 04 2023
accepted: 23 01 2024
medline: 14 2 2024
pubmed: 14 2 2024
entrez: 13 2 2024
Statut: aheadofprint

Résumé

Previous systematic reviews have provided heterogeneous and differing estimates for the efficacy of pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease (COPD). The aim of this review was to examine the efficacy of pulmonary rehabilitation programmes initiated within 3 weeks of hospital discharge following an exacerbation of COPD. An update of a previous Cochrane review was undertaken using the Cochrane Airways Review Group Specialised Register. Searches were conducted from October 2015 to August 2023 for studies that initiated pulmonary rehabilitation within 3 weeks of hospital discharge. Studies assessing the impact of solely inpatient pulmonary rehabilitation were excluded. Forest plots were generated using a generic inverse variance random effects method. Seventeen studies were included. Posthospital discharge pulmonary rehabilitation reduced hospital re-admissions (OR 0.48, 95% CI 0.30 to 0.77, I Pulmonary rehabilitation delivered posthospital discharge for exacerbation of COPD results in a reduction in hospital re-admissions and improvements in exercise capacity, health-related quality of life and dyspnoea in the absence of any intervention-related adverse events. CRD42023406397.

Identifiants

pubmed: 38350731
pii: thorax-2023-220333
doi: 10.1136/thorax-2023-220333
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Alex R Jenkins (AR)

Clinical Exercise and Respiratory Physiology Laboratory, Department of Kinesiology and Physical Education, Faculty of Education, McGill University, Montreal, QC, Canada alex.jenkins1108@outlook.com.

Chris Burtin (C)

REVAL-Rehabilitation Research Center, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium.
BIOMED-Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.

Pat G Camp (PG)

Centre for Heart Lung Innovation, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
Department of Physical Therapy, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.

Peter Lindenauer (P)

Department of Healthcare Delivery and Population Sciences, University of Massachusetts Chan Medical School - Baystate, Springfield, MA, USA.

Brian Carlin (B)

Sleep Medicine and Lung Health Consultants, Pittsburgh, Pennsylvania, USA.

Jennifer A Alison (JA)

Sydney School of Health Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Allied Health, Sydney Local Health District, Sydney, NSW, Australia.

Carolyn Rochester (C)

Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, CT, USA.
VA Connecticut Healthcare System, West Haven, CT, USA.

Anne E Holland (AE)

Respiratory Research@Alfred, Central Clinical School, Monash University, Melbourne, VIC, Australia.
Department of Physiotherapy, Alfred Health, Melbourne, VIC, Australia.
Institute for Breathing and Sleep, Heidelberg, VIC, Australia.

Classifications MeSH